2019-nCoV (Wuhan virus), a novel Coronavirus: Human-to-human transmission, travel-related cases, and vaccine readiness

Journal of Infection in Developing Countries

Volumn 14, Issue 1, 2020, Pages 3-17

  Ralph, Robyn ^a,b   Lew, Jocelyne ^a   Zeng, Tiansheng ^c   Francis, Magie ^d   Xue, Bei ^c,d   Roux, Melissa ^d   Ostadgavahi, Ali Toloue ^d   Rubino, Salvatore ^e   Dawe, Nicholas J ^d   Al Ahdal, Mohammed N ^f   Kelvin, David J ^c,d,g   Richardson, Christopher D ^d,g   Kindrachuk, Jason ^h   Falzarano, Darryl ^a,b   Kelvin, Alyson A ^d,g  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF SASSARI   (Italy)

^f KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^g IWK HEALTH CENTRE   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

Author keywords

2019 nCoV; Coronavirus; Human to human transmission; Vaccine readiness; Wuhan

Indexed keywords

2019 NOVEL CORONAVIRUS; 2019 NOVEL CORONAVIRUS INFECTION; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CHILL; CHINA; COMPUTER MODEL; CORONAVIRINAE; CORONAVIRUS INFECTION; DISEASE COURSE; DISEASE TRANSMISSION; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPNEA; FEVER; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; INFECTIOUS DISEASE MEDICINE; KNOWLEDGE; LYMPHOCYTOPENIA; MALAISE; MEDICAL RESEARCH; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PATHOGENESIS; PHYLOGENY; PUBLIC HEALTH; RECEPTOR BINDING; SARS CORONAVIRUS; THROMBOCYTOPENIA; TRAVEL RELATED DISEASE; UNIVERSITY HOSPITAL; VACCINATION; VIROLOGY; VIRUS ISOLATION; VIRUS REPLICATION; ANIMAL; BETACORONAVIRUS; CHEMISTRY; DISEASE CARRIER; GENETICS; PANDEMIC; SEQUENCE ANALYSIS; TRAVEL; VETERINARY MEDICINE; VIRUS PNEUMONIA; ZOONOSIS;

COVID-19; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRAL PROTEIN;

ANIMALS; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; DISEASE RESERVOIRS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; SEQUENCE ANALYSIS, PROTEIN; TRAVEL; VACCINATION; VIRAL PROTEINS; ZOONOSES;

EID: 85079141403     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.12425     Document Type: Article

References (82)

1. China, TSCIOotPsRo. Press Conference on Pneumonia Prevention and Control of the New Coronavirus Infection held 10 am Beijing time. Available from: https://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/42470/index.htm.
2. ProMed International Soceity for Infectious Diseases, PISfI, ProMed 20191230.6864153 Undiagnosed Pneumonia - China (Hubei): Request for Information. 2019.
3. Diseases, P.I.S.f.I. 20200102.6866757 Undiagnosed Pneumonia - China (Hubei) (01): Wildlife sales, market closed, Request for Information. 2020.
4. Diseases, P.I.S.f.I. 20200103.6869668 Undiagnosed Pneumonia - China (Hubei) (02): Updates, other countries responses, Request for Information. 2020.
5. Diseases, P.I.S.f.I. 20200105.6872267 Undiagnosed Pneumonia - China (Hubei) (03): Updates, severe acute respiratory syndrome, Middle East Respiratory Syndrome rouled rouled out, WHO, Request for Information. 2020.
6. Diseases, P.I.S.f.I. 20200108.6877694 Undiagnosed Pneumonia - China (Hubei) (05): Novel Coronavirus identified. 2020.
7. Diseases, P.I.S.f.I. 20200108.6878869 Undiagnosed Pneumonia - China (HU) (07): official confirmation of novel coronavirus. 2020.
8. Diseases, P.I.S.f.I. 20200110.6881082 Undiagnosed Pneumonia - China (Hubei) (08): Novel Coronavirus, WHO. 2020.
9. Diseases, P.I.S.f.I. 20200110.6883253 Undiagnosed Pneumonia - China (Hubei) (09): Novel Coronavirus, more iformation, first fatality. 2020.
10. Diseases, P.I.S.f.I. 20200113.6886644 Novel Coronavirus (02): Thailand ex China (Hubei) WHO. 2020.
11. Diseases, P.I.S.f.I. 20200114.6889527 Novel Coronavirus (04): China (Hubei), Thailand ex China, WHO. 2020.
12. Diseases, P.I.S.f.I. 20200115.6891515 Novel Coronavirus (05): China (HU), Japan ex China. 2020.
13. Diseases, P.I.S.f.I. 20200120.6899007 Novel Coronavirus (11) - China (Hubei) South Korea ex China. 2020.
14. Diseases, P.I.S.f.I. 20200121.6901757 Novel Coronavirus (12): China (Hubei) New fatality, healthcare workers, WHO. 2020.
15. World Health Organization (WHO) (2020) Diagnostics for novel coronavirus. Available: https://www.who.int/healthtopics/coronavirus/laboratory-diagnostics-for-novelcoronavirus. Accessed: 23 January 2020.
16. Canducci F, Debiaggi M, Sampaolo M, Marinozzi MC, Berre S, Terulla C, Gargantini G, Cambieri P, Romero E, Clementi M (2008) Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. J Med Virol 80: 716-723.
17. Jevsnik M, Ursic T, Zigon N, Lusa L, Krivec U, Petrovec M (2012) Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease. BMC Infect Dis 12: 365.
18. Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 1282: 1-23.
19. Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad JL, Ho LM, Thach TQ, Chau P, Chan KP, Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau EM, Ferguson NM, Anderson RM (2003) Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 361: 1761-1766.
20. de Wit E, van Doremalen N, Falzarano D, Munster VJ (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14: 523-534.
21. Walston S, Al-Harbi Y, Al-Omar B (2008) The changing face of healthcare in Saudi Arabia. Ann Saudi Med 28: 243-250.
22. AL-Ahmadi H, Roland M (2005) Quality of primary health care in Saudi Arabia: a comprehensive review. Int J Qual Health Care17: 331-346.
23. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, Makhdoom HQ, Zumla AI, Memish ZA (2013) Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13: 752-761.
24. Hunter JC, Nguyen D, Aden B, Al Bandar Z, Al Dhaheri W, Abu Elkheir K, Khudair A, Al Mulla M, El Saleh F, Imambaccus H, Al Kaabi N, Sheikh FA, Sasse J, Turner A, Abdel Wareth L, Weber S, Al Ameri A, Abu Amer W, Alami NN, Bunga S, Haynes LM, Hall AJ, Kallen AJ, Kuhar D, Pham H, Pringle K, Tong S, Whitaker BL, Gerber SI, Al Hosani FI (2016) Transmission of Middle East Respiratory Syndrome Coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis 22: 647-656.
25. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B (2014) Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160: 389-397.
26. Guery B, Poissy J, el Mansouf L, Sejourne C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf A, ME-Cs group (2013) Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 381: 2265-2272.
27. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM (2013) Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 368: 2487-2494.
28. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367: 1814-1820.
29. Al-Tawfiq JA, Hinedi K, Ghandour J, Khairalla H, Musleh S, Ujayli A, Memish ZA (2014) Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis 59: 160-165.
30. Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA (2014) Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol 203: 782-787.
31. Zumla A, Hui DS, Perlman S (2015) Middle East respiratory syndrome. Lancet 386: 995-1007.
32. Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY (2015) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28: 465-522.
33. Albarrak AM, Stephens GM, Hewson R, Memish ZA (2012) Recovery from severe novel coronavirus infection. Saudi Med J 33: 1265-1269.
34. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, Almakhlafi GA, Albarrak MM, Memish ZA, Albarrak AM (2014) Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 14: 1090-1095.
35. Chan JF, Yao Y, Yeung ML, Deng W, Bao L, Jia L, Li F, Xiao C, Gao H, Yu P, Cai JP, Chu H, Zhou J, Chen H, Qin C, Yuen KY (2015) Treatment with lopinavir/ritonavir or interferonbeta1b improves outcome of MERS-CoV infection in a Nonhuman primate model of common marmoset. J Infect Dis 212: 1904-1913.
36. Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG Jr., Frieman MB, Holbrook MR, Jahrling PB, Hensley L (2014) Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol 95: 571-577.
37. Chan JF, Chan KH, Kao RY, To KK, Zheng BJ, Li CP, Li PT, Dai J, Mok FK, Chen H, Hayden FG, Yuen KY (2013) Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 67: 606-616.
38. Arabi YM, Alothman A, Balkhy HH, Al-Dawood A, AlJohani S, Al Harbi S, Kojan S, Al Jeraisy M, Deeb AM, Assiri AM, Al-Hameed F, AlSaedi A, Mandourah Y, Almekhlafi GA, Sherbeeni NM, Elzein FE, Memon J, Taha Y, Almotairi A, Maghrabi KA, Qushmaq I, Al Bshabshe A, Kharaba A, Shalhoub S, Jose J, Fowler RA, Hayden FG, Hussein MA, Mtg And the (2018) Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 19: 81.
39. Chan PK, Chan MC (2013) Tracing the SARS-coronavirus. J Thorac Dis 5 Suppl 2: 118-121.
40. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, Chen QX, Gao YW, Zhou HQ, Xiang H, Zheng HJ, Chern SW, Cheng F, Pan CM, Xuan H, Chen SJ, Luo HM, Zhou DH, Liu YF, He JF, Qin PZ, Li LH, Ren YQ, Liang WJ, Yu YS, Anderson L, Wang M, Xu RH, Wu XW, Zheng HY, Chen JD, Liang G, Gao Y, Liao M, Fang L, Jiang LY, Li H, Chen F, Di B, He LJ, Lin JY, Tong S, Kong X, Du L, Hao P, Tang H, Bernini A, Yu XJ, Spiga O, Guo ZM, Pan HY, He WZ, Manuguerra JC, Fontanet A, Danchin A, Niccolai N, Li YX, Wu CI, Zhao GP (2005) Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA 102: 2430-1435.
41. Shi Z, Hu Z (2008) A review of studies on animal reservoirs of the SARS coronavirus. Virus Res 133: 74-87.
42. Memish ZA, Cotton M, Meyer B, Watson SJ, Alsahafi AJ, Al Rabeeah AA, Corman VM, Sieberg A, Makhdoom HQ, Assiri A, Al Masri M, Aldabbagh S, Bosch BJ, Beer M, Muller MA, Kellam P, Drosten C (2014) Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis 20: 1012-1015.
43. Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, Burbelo PD, de Wit E, Munster VJ, Hensley LE, Zalmout IS, Kapoor A, Epstein JH, Karesh WB, Daszak P, Mohammed OB, Lipkin WI (2014) Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio 5: e00884-14.
44. Willman M, Kobasa D, Kindrachuk J (2019) A Comparative analysis of factors influencing two outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea. Viruses 11: 11. pii: E1119.
45. Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, Leung GM, Lam TH, Hedley AJ (2004) Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci 359: 1091-1105.
46. Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT (2015) Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill 20: 7-13.
47. Li F (2016) Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 3: 237-261.
48. Qiu W, Chu C, Mao A, Wu J (2018) The impacts on health, society, and economy of SARS and H7N9 outbreaks in China: A case comparison study. J Environ Public Health 2018: 2710185.
49. Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W, Zhan J, Wang S, Xie Z, Zhuang H, Wu B, Zhong H, Shao H, Fang W, Gao D, Pei F, Li X, He Z, Xu D, Shi X, Anderson VM, Leong AS (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202: 415-424.
50. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203: 631-637.
51. Lambeir AM, Durinx C, Scharpe S, De Meester I (2003) Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40: 209-294.
52. Widagdo W, Raj VS, Schipper D, Kolijn K, van Leenders G, Bosch BJ, Bensaid A, Segales J, Baumgartner W, Osterhaus A, Koopmans MP, van den Brand JMA, Haagmans BL (2016) Differential expression of the Middle East Respiratory Syndrome Coronavirus receptor in the upper respiratory tracts of humans and dromedary camels. J Virol 90: 4838-4842.
53. Menachery VD, Yount Jr. BL, Sims AC, Debbink K, Agnihothram SS, Gralinski LE, Graham RL, Scobey T, Plante JA, Royal SR, Swanstrom J, Sheahan TP, Pickles RJ, Corti D, Randell SH, Lanzavecchia A, Marasco WA, Baric RS (2016) SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci USA 113: 3048-3053.
54. Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, Wong SK, Huang IC, Xu K, Vasilieva N, Murakami A, He Y, Marasco WA, Guan Y, Choe H, Farzan M (2005) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J 24: 1634-1643.
55. van Zundert GCP, Rodrigues J, Trellet M, Schmitz C, Kastritis PL, Karaca E, Melquiond ASJ, van Dijk M, de Vries SJ, Bonvin A (2016) The HADDOCK2.2 Web server: User-friendly integrative modeling of biomolecular complexes. J Mol Biol 428: 720-725.
56. Li W, Greenough TC, Moore MJ, Vasilieva N, Somasundaran M, Sullivan JL, Farzan M, Choe H (2004) Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. J Virol 78: 11429-114233.
57. Li F, Li W, Farzan M, Harrison SC (2005) Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309: 1864-1868.
58. Weber DS, Warren JJ (2019) The interaction between methionine and two aromatic amino acids is an abundant and multifunctional motif in proteins. Arch Biochem Biophys 672: 108053.
59. Agnihothram S, Gopal R, Yount BL Jr, Donaldson EF, Menachery VD, Graham RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS (2014) Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J Infect Dis 209: 995-1006.
60. Yong CY, Ong HK, Yeap SK, Ho KL, Tan WS (2019) Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus. Front Microbiol 10: 1781.
61. Almazan F, DeDiego ML, Sola I, Zuniga S, Nieto-Torres JL, Marquez-Jurado S, Andres G, Enjuanes L (2013) Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. mBio 4: e00650-13.
62. DeDiego ML, Alvarez E, Almazan F, Rejas MT, Lamirande E, Roberts A, Shieh WJ, Zaki SR, Subbarao K, Enjuanes L (2007) A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol 81: 1701-1713.
63. van Doremalen N, Munster VJ (2015) Animal models of Middle East respiratory syndrome coronavirus infection. Antiviral Res 122: 28-38.
64. Li F (2015) Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J Virol 89: 1954-1964.
65. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stohr K, Peiris JS, Osterhaus AD (2003) Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263-270.
66. Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, Peiris JS, Lim W, Osterhaus AD (2003) Virology: SARS virus infection of cats and ferrets. Nature 425: 915.
67. Banner D, Kelvin AA (2012) The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development. J Infect Dev Ctries 6: 465-9.
68. Wentworth DE, Gillim-Ross L, Espina N, Bernard KA (2004) Mice susceptible to SARS coronavirus. Emerg Infect Dis 10: 1293-1296.
69. Roberts A, Deming D, Paddock CD, Cheng A, Yount B, Vogel L, Herman BD, Sheahan T, Heise M, Genrich GL, Zaki SR, Baric R, Subbarao K (2007) A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 3: e5.
70. Agrawal AS, Garron T, Tao X, Peng BH, Wakamiya M, Chan TS, Couch RB, Tseng CT, (2015) Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol 89: 3659-3670.
71. Al-Ahmadi, Roland M (2005) Quality of primary health care in Saudi Arabia: a comprehensive review. Int J Qual Health Care 17: 331-346.
72. Wu F, Zhao S, Yu B, Chen YM, Wang W, Hu Y, Song ZG, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ (2020) A novel coronavirus associated with a respiratory disease in Wuhan of Hubei province, China. NCBI.
73. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
74. Kumar S, Stecher G, Tamura K (2016) MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 33: 1870-1874.
75. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Soding J, Thompson JD, Higgins DG (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7: 539.
76. Robert X, Gouet P (2014) Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 42: 320-324.
77. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10: 845-858.
78. Bhattacharya D, Nowotny J, Cao R, Cheng J (2016) 3Drefine: an interactive web server for efficient protein structure refinement. Nucleic Acids Res 44: 406-409.
79. Holm L (2019) Benchmarking fold detection by DaliLite v.5. Bioinformatics 35: 5326-5327.
80. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774-797.
81. Jurrus E, Engel D, Star K, Monson K, Brandi J, Felberg LE, Brookes DH, Wilson L, Chen J, Liles K, Chun M, Li P, Gohara DW, Dolinsky T, Konecny R, Koes DR, Nielsen JE, Head-Gordon T, Geng W, Krasny R, Wei GW, Holst MJ, McCammon JA, Baker NA (2018) Improvements to the APBS biomolecular solvation software suite. Protein Sci 27: 112-128.
82. Schrodinger, LLC. The PyMOL Molecular Graphics System, Version 2.1.1.